Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.530
-0.080 (-3.05%)
Nov 21, 2024, 11:14 AM EST - Market open
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $68.45 million as of November 21, 2024. Its market cap has increased by 115.93% in one year.
Market Cap
68.45M
Enterprise Value
-25.17M
1-Year Change
115.93%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $68.45M, an increase of 636.02%. That is a compound annual growth rate of 26.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 74.30M | -46.51% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 74.42M |
| MDxHealth | 74.24M |
| Ovid Therapeutics | 73.14M |
| Inotiv | 72.55M |
| BioAtla | 72.52M |
| Armata Pharmaceuticals | 71.64M |
| Vivani Medical | 71.28M |
| CytomX Therapeutics | 69.86M |